Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms.
Open Access
- 1 August 1994
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 38 (2), 131-137
- https://doi.org/10.1111/j.1365-2125.1994.tb04336.x
Abstract
1. The primary metabolism of diazepam was studied in human liver microsomes in order to investigate the kinetics and to identify the cytochrome P450 (CYP) isoforms responsible for the formation of the main diazepam metabolites, temazepam and N-desmethyldiazepam. 2. The formation kinetics of both metabolites were atypical and consistent with the occurrence of substrate activation. A sigmoid Vmax model equivalent to the Hill equation was used to fit the data. The degree of sigmoidicity was greater for temazepam formation than for N- desmethyldiazepam formation, so that the ratio of desmethyldiazepam:temazepam formation increased as the substrate (diazepam) concentration decreased. 3. alpha-Naphthoflavone activated both reactions but with a greater effect on temazepam formation than on N-desmethyldiazepam formation. In the presence of 25 microM alpha- naphthoflavone the kinetics for both pathways were approximated by Michaelis-Menten kinetics. 4. Studies with a series of CYP isoform selective inhibitors and with an inhibitory anti-CYP2C antibody indicated that temazepam formation was carried out mainly by CYP3A isoforms, whereas the formation of N-desmethyldiazepam was mediated by both CYP3A isoforms and S-mephenytoin hydroxylase.Keywords
This publication has 32 references indexed in Scilit:
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Metabolism of diazepam and related benzodiazepines by human liver microsomesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1992
- Diazepam metabolism by rat and human liver in vitro: inhibition by mephenytoinXenobiotica, 1992
- Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspectsChemical Research in Toxicology, 1991
- Factors influencing the metabolism of DiazepamPharmacology & Therapeutics, 1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomesBiochemistry, 1990
- Desmethyldiazepam Pharmacokinetics: Studies Following Intravenous and Oral Desmethyldiazepam, Oral Clorazepate, and Intravenous DiazepamThe Journal of Clinical Pharmacology, 1988
- Pharmacokinetic Model for Diazepam and its Major Metabolite Desmethyldiazepam Following Diazepam AdministrationJournal of Pharmaceutical Sciences, 1983
- Delayed Clearance of Diazepam Due to CimetidineNew England Journal of Medicine, 1980